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n the United States, diabetes mellitus is the seventh leading cause of death, and 65% of these deaths are attributable to cardiovascular disease or stroke or to both. 1, 2 Moreover, diabetes mellitus is an established and independent risk factor for stroke and is associated with a 1.8-to ≈6-fold increased risk compared with nondiabetic subjects. 2, 3 Currently, 12.2% (30.3 million) US adults over the age of 18 years has diabetes mellitus with 23.8% (7.2 million) unaware they have diabetes mellitus. 1 Prediabetes, a precursor to type 2 diabetes mellitus, is estimated to occur in 33.9% (84.1 million) US adults. 1 Moreover, a metaanalysis of 102 prospective studies reported that persons with diabetes mellitus had a 2.3× higher risk of developing ischemic stroke and a 1.6× higher risk of developing hemorrhagic stroke compared with nondiabetics. 4 Among patients admitted for acute stroke, diabetes mellitus was associated with a higher risk of death, functional dependency, and stroke recurrence. 5, 6 Hyperglycemia is a common problem in persons with diabetes mellitus after an acute stroke. 5, 6 Elevations in serum glucose can be because of many factors, such as age, obesity, and physiological stress. Maintaining therapeutic blood glucose levels postacute stroke can present extreme challenges. Therefore, reasonably tight, yet therapeutic, control of hyperglycemia in persons with diabetes mellitus after a stroke must be a priority. The purpose of this article is to describe (1) major evidence-based interventions to maintain normal glucose levels and improve outcomes in persons with diabetes mellitus after an acute stroke, and (2) the critical role nurses play in the prevention and control of hyperglycemia in persons with diabetes mellitus after a stroke.
Pathophysiology
Several mechanisms associated with diabetes mellitus lead to stroke. Persons with diabetes mellitus have stiffer arteries, early structural changes, and decreased elasticity compared with individuals without diabetes mellitus. 7 The physiological stress of a stroke contributes to increased circulating counter regulatory hormones (cortisol, catecholamine's, growth hormone, glucagon) and proinflammatory cytokines. 7 These combined factors lead to excessive glucose production and reduced glucose uptake. 7 Hyperglycemia has also been shown to worsen acute ischemic brain injury (increase brain edema, brain herniation, infarct size, and decrease reperfusion) that potentially increase the risk of morbidity and mortality in persons with diabetes mellitus. [5] [6] [7] Higher glucose levels on admission in persons with and without diabetes mellitus have been associated with increased mortality, worse poststroke outcomes, and stroke recurrence. 8 It has been further reported that ≈20% to 35% of hospitalized patients have a history of diabetes mellitus, and another 58% without a history of diabetes mellitus on admission have a plasma glucose >110 mg/dL. 9 Thus, maintaining glucose levels within normal ranges are important for long-term survival poststroke in persons with diabetes mellitus.
Evidence-Based Guideline for Glucose Management During and Poststroke
The American Heart Association/American Stroke Association 10 and the American Diabetes Association 11 have provided guidelines for the early management of patients with acute ischemic stroke recommending serum glucose concentrations in the range of 140 to 180 mg/dL (7.8-10 mmol/L) during the first 24 hours in all hospitalized patients. Typically, hyperglycemia in the acute stroke setting is treated with subcutaneous insulin through a sliding scale. Normalization of blood glucose during the first 48 hours of hospitalization has survival benefits in patients experiencing ischemic stroke. 12 The National Institute of Neurological Disorders and Stroke-funded THIS (Treatment of Hyperglycemia in Ischemic Stroke) 12 and the GRASP (Glucose Regulation in Acute Stroke Patients) 13 trials both demonstrated safety and feasibility of insulin infusion therapy for intensive glucose control in patients with acute ischemic stroke. However, a recent systematic review of 11 randomized controlled trials involving 1583 participants determined that intensive glucose control (72-135 mg/dL) using insulin, immediately after acute ischemic stroke, found no differences between intensive or convention glucose control on dependency, neurological deficit, or mortality at 30 or 90 days.
14 Similar results were found in a subgroup analysis between persons with or without diabetes mellitus; however, increase in severe hypoglycemia was reported. The authors concluded no evidence supported the use of intensive insulin therapy for tight glucose control after acute stroke in persons with or without diabetes mellitus.
14 Yet, the GLIAS-II (Glycemia in Acute Stroke II) study demonstrated that glucose levels ≥155 mg/dL were associated with poorer outcomes poststroke. 15 As a result, the Society of Hospital Medicine provides a free comprehensive e216
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resource manual that includes evidence-based guidelines to assist nurses in developing strategies and protocols to monitor glucose levels in the hospital setting. 16 Their manual contains multiple examples of insulin administration protocols, resources, and suggestions that can be adapted according to the needs of the institution on developing and implementing intensive glucose management protocols (eg, personnel, time, training, charting, and tracking capability, etc). 16 The SHINE trial (Stroke Hyperglycemia Insulin Network Effort), a multicenter randomized controlled trial of 1400 patients, is currently being analyzed to assess the targeted glucose concentration (80-130 mg/dL) that would be safe and result in improved 3-month poststroke outcome. 17 This study will provide valuable evidence about the optimal management of hyperglycemia, as well as the development of a standard protocol that describes the optimal level of glucose in acute stroke as well as its efficacy and safety. In addition, the SHINE study will produce data on the frequency of glucose monitoring needed to avoid the onset of both hyperglycemia and hypoglycemia.
Glycemic Targets and Recommendations
The benefits of glycemic control on morbidity reduction through implementation of intravenous insulin protocols administered using evidence-based practice algorithms are well described in the literature. [16] [17] [18] [19] [20] [21] The nurse plays a pivotal role in consistently monitoring and safety managing glucose levels in both the short-and long-term care of patients during and after stroke. [22] [23] [24] [25] In clinical practice, the first step is to document glucose levels on admission and in the poststroke state to evaluate its severity and duration. It is recommended that insulin therapy be initiated for treatment of persistent hyperglycemia starting at a threshold 180 mg/dL. 10, 11 Once insulin therapy is started, a target glucose range of 140 to 180 mg/ dL is recommended for the majority of critically ill patients, including those with diabetes mellitus. A meta-analysis of >26 studies, including the NICE-SUGAR (Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation) study, revealed increased rates of severe hypoglycemia (blood glucose <40 mg/dL) and mortality in tightly versus moderately controlled cohorts. 25 In the GLIAS-II study, it was demonstrated that lack of response to conventional glucose management (<155 mg/dL) within the first 48 hours was associated with poor outcomes poststroke. 15 Nurses should perform ongoing assessments to evaluate the response to glucose management, including changes in the trajectory of glucose levels, intake and output, nutritional status, illness/ infection, renal function, and neurological function (cognitive status). Early documentation and immediate correction of these abnormalities are important to long-term outcomes of patients poststroke, including those with diabetes mellitus.
Nursing Implications
An essential responsibility of the nurse is to manage hyperglycemia during and poststroke, as well as understand the pathophysiology of hyperglycemia and how its effective control prevents devastating long-term morbidity and mortality. 16, [22] [23] [24] [25] Guidelines have been provided by the American Heart Association/American Stroke Association, American Diabetes Association, and the Society of Hospital Medicine. 10, 11, 16 Because of their continued interactions with patients, nurses frequently serve as an essential bridge of care between the patient, their providers, and their families. Investing in initial and continuing diabetes education will pay significant dividends in the long-term outcomes of persons with diabetes mellitus poststroke. Given the large number of nurses at most institutions, a multifaceted approach, such as 1:1 encounters, web-based modules, including educational modules of primary care and self-management content (eg, insulin protocols, case studies), are suggested strategies. Unit-based meetings and annual data review should be a regular component of nursing/provider in-services, grand rounds, and continuing education programs to keep all parties engaged in patient care and updated protocols. 26 Once patients are stabilized, it is important for the nurse to create an individualized diabetes management plan (ie, lifestyle recommendations; changes in physical activity [walking 10 000 steps/d if tolerated]: dietary recommendation [low carbohydrate diet, low sodium and cholesterol, increase in fresh fruits and vegetables] and medications), as well as poststroke care with the patient and their families. 11, 27 Table I in the online-only Data Supplement is a synthesis of the current literature reflecting lifestyle management poststroke in persons with diabetes mellitus. Nurses and discharge planners should also assist the patient and caregivers identify appropriate resources, such as the American Association of Diabetes Educators, American Diabetes Association, American Stroke Association, Life after a stroke, StrokeAide.com, or other rehabilitation services located within the community for continued support and management.
Conclusions
The danger of poststroke hyperglycemia is well established in persons with and without diabetes mellitus. Data confirm a strong association between hyperglycemia and poor outcomes, in persons with diabetes mellitus as well as those with high admission glucose levels. Table II in the onlineonly Data Supplement provides a summary of the literature of evidence-based guidelines of glucose levels poststroke. Although there is compelling evidence that hyperglycemia has an effect on stroke outcome, debate continues as to whether the effect is independent of the influence of diabetes mellitus or initial stroke severity. The pathogenesis of hyperglycemia and the pathophysiology that underlie detrimental effects of hyperglycemia remain unclear. A distinction between unknown diabetes mellitus and nondiabetic hyperglycemia seems important because prognosis and effect of intervention have been shown to differ in these 2 groups. The documentation of glucose on admission is essential. When treating hyperglycemia, the nurse should be cautious in the correction of glucose to avoid hypoglycemia, all of which can be detrimental to the brain and affect future patient outcomes. Careful use of insulin infusion protocols seems advisable when accompanied with frequent glucose monitoring and documentation, especially during the first 48 hours poststroke. Rigorous studies, such as the SHINE study, are needed to assess the value of insulin therapy and to determine the optimal blood glucose targets in patients with diabetes mellitus poststroke. 17 Nurses continue to be
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an essential team member in monitoring and documenting glucose levels, patient outcomes, and education to patient, family, and providers.
